Composition containing a gold (i) complex and cancer cells

a technology of complexes and cancer cells, applied in the field of therapeutic gold (i) complexes and pharmaceutical compositions thereof, can solve problems such as limiting the applicability of complexes

Inactive Publication Date: 2018-09-27
KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The gold(I) complex demonstrates significant cytotoxicity against malignant cells with non-cisplatin-like pharmacodynamic and pharmacokinetic properties, providing a promising candidate for treating cancer, especially cisplatin-resistant tumors.

Problems solved by technology

Despite the great success of cisplatin and its analogues, the platinum-containing drugs manifests systemic toxicity and clinical inefficiency against resistant tumors, therefore limiting their domain of applicability (Rabik, A. C.; Dolan, E. M. Molecular mechanisms of resistance and toxicity associated with platinating agents.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition containing a gold (i) complex and cancer cells
  • Composition containing a gold (i) complex and cancer cells
  • Composition containing a gold (i) complex and cancer cells

Examples

Experimental program
Comparison scheme
Effect test

example 1

Materials and Methods

[0140]Ethidium bromide (EB) sodium N,N-dimethyldithiocarbamate hydrate (DMDT), and sodium N,N-diethyldithiocarbamate hydrate (DEDT) were purchased from Sigma-Aldrich Tris-(hydroxymethyl)aminomethane (Tris buffer) (Merck), adenosine-5′-monophosphate disodium salt (5′-AMP), cytidine-5′-monophosphate disodium salt hydrate (5′-CMP), guanosine-5′-monophosphate disodium salt (5′-GMP), thymine-5′-monophosphate (5′-TMP), and CH3OH were obtained from Fluka Chemicals Co. and were stored at −20° C. Disodium salt of CT-DNA (calf thymus DNA) was purchased from Sigma Chem. Co. and was stored at 4° C. All reagents as well as solvents were used as received. Human breast cancer cell lines, MDA-MB231 and MCF7, were provided by American Type Culture Collection (ATCC) Cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal calf serum (FCS), penicillin (100 kU L−1) and streptomycin (0.1 g L−1) at 37° C. in a 5%, CO2-95% air atmosphere, MTT (3-(4,5-...

example 2

Synthesis of Therapeutic Gold(I) Complexes

[0141]Following the previous studies on mixed phosphine gold(I) dithiocarbamate compounds with antitumor activity and in continuation of the interest in the synthesis of gold(I) complexes to better understand the chemical and physical behavior of biologically relevant dithiocarmato(phosphine)gold(I) complexes, gold(I) complexes 1-5 were synthesized and fully characterized by elemental analysis, FT1R, NMR measurements and UV-Vis spectroscopic techniques (Altaf, M,: Monim-ul-Mehboob, M.; Seliman, A. A.; Sohail, M.; Wazeer, I. M.; Isab, A. A.:, Li, L.; Dhuna, V.; Bhatia, G.; Dhuna, K. Synthesis, Characterization and anticancer activity of gold(I) complexes that contain tri-teri-butylphosphine and dialkyldithiocarbamate ligands. Eur. J. Med. Chem. 2015, 95, 464-472; and Altaf M.; Monim-ul-Mehboob, M; Isab, A. A.; Bhatia, G.; Dhuna, K.; Altuwaijri, S. The synthesis, spectroscopic characterization and anticancer activity of new mono and binuclear ...

example 3

Electronic Spectra

[0144]Electronic spectra were obtained for the gold(I) complexes using Lambda 200, Perkin-Elmer UV-Vis spectrometer. UV-Vis spectroscopy was used to determine the stability of the complexes in DMSO. Electronic spectra were recorded on freshly prepared samples of each complex in a buffer at room temperature. The resulting UV-Vis absorption data are shown in Table 2.

TABLE 2λmax values derived from UV-Vis spectra for Au(I) complexes 1-5Complexλmax (nm)(Me)3PAu(S2CN{Me}2) (1)270, 321(Et)3PAu(S2CN{Me}2) (2)270, 320(Me)3PAu(S2CN{Et}2) (3)270, 321(Et)3PAu(S2CN{Et}2) (4)272, 333(i-Pr)3PAu(S2CN{Me}2) (5)270, 322

[0145]The optical electronic absorption spectra show a similar pattern for all of the complexes. The gold(I) completes 1-5 absorbed intensely at two regions, 270-272 nm and 321-333 nm, which were attributed to the intramolecular intraligand transition corresponding to π→π° in the NCS and CSS moieties, respectively (Yang, Y.; Zuo, B.; Li, J.; G. Chen, G. Studies on th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Gold(I) complex with mixed ligands as an anticancer agent. The gold(I) ion is coordinated to a dithiocarbamate ligand and a phosphorus-containing ligand (e.g. phosphines). Also described are a pharmaceutical composition incorporating the gold(I) complex, a methods of synthesizing the gold(I) complex, and a method for treating cancer.

Description

RELATED APPLICATIONS[0001]This application claims the priority of the filing date of the U.S. Provisional Patent Application No. 62 / 326,389 filed Apr. 22, 2016, the disclosure of which is hereby incorporated herein by reference in its entirety.STATEMENT OF FUNDING ACKNOWLEDGEMENT[0002]This project was funded by the National Plan for Science and Innovation (MARIFAH)—King Abdulaziz City for Science and Technology (KACST) through the Science and Technology Unit at King Fahd University of Petroleum and Minerals (KFUPM) of Saudi Arabia, award No. 14-MED64-04.BACKGROUND OF THE DISCLOSURETechnical Field[0003]The present disclosure relates to therapeutic gold(I) complexes, a pharmaceutical composition thereof, and a method of treating cancer.Description of the Related Art[0004]The “background” description provided herein is for the purpose of generally presenting the context of the disclosure. Work of the presently named inventors, to the extent it is described in this background section, a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(United States)
IPC IPC(8): C07F9/50C12Q1/6886G01N33/574A61K31/66A61K45/06A61K9/00
CPCC12Q2600/156C12Q1/6886G01N33/57415C07F9/5045A61K31/66A61K45/06A61K9/0053A61N1/30G01N2800/52
InventorAL-JAROUDI, SAID S.ALHOSHANI, ALIALTAF, MUHAMMADISAB, ANVARHUSEIN ABDULKADIR
OwnerKING FAHD UNIVERSITY OF PETROLEUM AND MINERALS